03/17/2014 - 8:48am

Abbott voluntarily recalled the FreeStyle Blood Glucose Meter and the FreeStyle Flash Blood Glucose Meter, neither of which have been in production since 2010.

03/06/2014 - 1:20pm

Study results announced Thursday by Novo Nordisk and collaborative partners found that participation in diabetes education is associated with a greater sense of well-being and the ability to self-manage diabetes.

03/03/2014 - 1:48pm

An international team led by researchers at the Broad Institute and Massachusetts General Hospital has identified mutations in a gene that can reduce the risk of developing Type 2 diabetes, even in people who have such risk factors as obesity and old age, the group announced Sunday.

03/03/2014 - 11:26am

AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

02/12/2014 - 10:46am

America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide, the Pharmaceutical Research and Manufacturers of America announced Tuesday.

02/07/2014 - 10:02am

The United States Hispanic Chamber of Commerce welcomed Boehringer Ingelheim Pharmaceuticals to its family of corporate members as a strategic partner.

01/21/2014 - 12:31pm

Novo Nordisk has launched a new insulin pen designed for children with diabetes.

01/14/2014 - 2:58pm

A physician in Mississippi is warning that one-third of the state's population could have diabetes in less than two decades, according to published reports.

01/08/2014 - 12:47pm

The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said.